Clinical Trials Browser

OTHER × Prostatic Neoplasms × Robotics × Clear all

NCT07025369 2026-03-13

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

Phase 2 Recruiting

Prostatic Neoplasms

NCT06389786 2025-10-24

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

Phase NA Recruiting

Prostatic Neoplasms